Angiotensin‐converting enzyme inhibitors attenuate circulating CAF22 and physical decline in congestive heart failure: Diagnostic implications of CAF22

Documenti analoghi

• Semaglutide use is associated with neuromuscular junction degradation in older adults with type II diabetes mellitus
  di: Rizwan Qaisar, et al.
  Pubblicazione: (2025)
• The anti‐fibrotic effects of novel heart failure pharmacotherapies in advanced heart failure patients
  di: Dávid Nagy, et al.
  Pubblicazione: (2025)
• SEW2871 attenuates myocyte necroptosis in heart failure through inhibition of oxidative stress and inflammatory cytokines
  di: Hong‐Xia Guo, et al.
  Pubblicazione: (2025)
• An orally available Cav2.2 calcium channel inhibitor for the treatment of neuropathic pain
  di: Janine Kutzsche, et al.
  Pubblicazione: (2024)
• Enhancing antitumour response to proteasome inhibitors with inhibitors of insulin‐degrading enzyme, a new molecular vulnerability in multiple myeloma
  di: Laetitia Lesire, et al.
  Pubblicazione: (2026)